Summary of Study ST000362

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000288. The data can be accessed directly via it's Project DOI: 10.21228/M8TC7S This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST000362
Study TitleAssociations between 69 Sphingolipids and Emphysema, Chronic Bronchitis, Exacerbations, and FEV1/FVC
Study TypeAssociation Study
Study SummaryOne hundred twenty-nine current and former smokers from the COPDGene cohort had 69 distinct sphingolipid species detected in plasma by targeted mass spectrometry. Of these, 23 were also measured in 131 plasma samples (117 independent subjects) using an untargeted platform in an independent laboratory. Regression analysis with adjustment for clinical covariates, correction for false discovery rate, and metaanalysis were used to test associations between COPD subphenotypes and sphingolipids. Peripheral blood mononuclear cells were used to test associations between sphingolipid gene expression and plasma sphingolipids.
Institute
National Jewish Health
DepartmentMedicine
LaboratoryBowler
Last NameJacobson
First NameSean
Address1400 Jackson St, Denver, CO 80206
Emailjacobsons@njhealth.org
Phone(303) 398-1355
Submit Date2016-03-10
Analysis Type DetailLC-MS
Release Date2016-09-23
Release Version1
Sean Jacobson Sean Jacobson
https://dx.doi.org/10.21228/M8TC7S
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR000288
Project DOI:doi: 10.21228/M8TC7S
Project Title:Plasma Sphingolipids Associated with Chronic Obstructive Pulmonary Disease Phenotypes
Project Type:Association Study
Project Summary:Sphingolipids association meta-analysis study from human sources
Institute:National Jewish Health
Department:Medicine
Laboratory:Bowler
Last Name:Jacobson
First Name:Sean
Address:1400 Jackson St, Denver, CO 80206
Email:jacobsons@njhealth.org
Phone:(303) 398-1355

Subject:

Subject ID:SU000383
Subject Type:Animal
Subject Species:Homo sapiens
Taxonomy ID:9606
Species Group:Human

Factors:

Subject type: Animal; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Severe_Exacerbations Chronic_Bronchitis GoldStage Gender SmokingStatus
SA01615524757L1 1 3 1 -
SA01615610056H1 1 4 2 -
SA01614912900A1 - 2 2 -
SA01615018213L1 - 3 1 -
SA01615121272Y1 - 3 1 1
SA01615221829V1 - 4 1 -
SA01615324064G1 - 4 2 -
SA01615421999U1 - 4 2 -
SA01615818869K2 1 3 1 -
SA01615721254W2 - 3 1 1
SA01615919059G3 - 3 1 -
SA01616018233R3 - 3 2 -
SA01616119156E3 - 4 2 -
SA01616222182C5 - 4 1 -
SA01613018951V- 1 1 1 1
SA01613124293V- 1 2 1 -
SA01613225218M- 1 2 1 -
SA01613318425A- 1 2 1 -
SA01613420230D- 1 2 1 1
SA01613520533V- 1 2 1 1
SA01613621842N- 1 2 1 1
SA01613717719M- 1 2 1 1
SA01613822662Q- 1 2 2 -
SA01613918793D- 1 2 2 1
SA01614022460E- 1 2 2 1
SA01614114457T- 1 3 1 -
SA01614225239U- 1 3 1 -
SA01614324536V- 1 3 1 -
SA01614416545A- 1 3 1 -
SA01614511699C- 1 3 1 1
SA01614624451N- 1 3 1 1
SA01614718048W- 1 4 1 1
SA01614823504D- 1 4 2 1
SA01612825229R- 1 - 1 -
SA01612917974C- 1 - 1 1
SA01606922035P- - 1 1 -
SA01607018962A- - 1 1 -
SA01607124438V- - 1 1 -
SA01607220102U- - 1 1 -
SA01607317855U- - 1 1 -
SA01607415974S- - 1 1 1
SA01607519648Z- - 1 1 1
SA01607623351E- - 1 1 1
SA01607716559L- - 1 2 -
SA01607821957E- - 1 2 -
SA01607917577S- - 1 2 -
SA01608017066T- - 1 2 -
SA01608121967H- - 1 2 1
SA01608220778Z- - 2 1 -
SA01608310544U- - 2 1 -
SA01608420378J- - 2 1 -
SA01608514724Q- - 2 1 -
SA01608624714T- - 2 1 -
SA01608716069U- - 2 1 -
SA01608817144N- - 2 1 -
SA01608918497Z- - 2 1 -
SA01609023109X- - 2 1 -
SA01609118990F- - 2 1 -
SA01609222488A- - 2 1 -
SA01609317932M- - 2 1 1
SA01609415973Q- - 2 1 1
SA01609521601R- - 2 2 -
SA01609623622J- - 2 2 -
SA01609711220Z- - 2 2 -
SA01609821772S- - 2 2 -
SA01609910072F- - 2 2 -
SA01610016619D- - 2 2 -
SA01610124437T- - 2 2 -
SA01610215841Z- - 2 2 -
SA01610322068E- - 3 1 -
SA01610424447W- - 3 1 -
SA01610524309K- - 3 1 -
SA01610620534X- - 3 1 -
SA01610715520F- - 3 1 -
SA01610819785J- - 3 1 -
SA01610918518H- - 3 1 -
SA01611021044L- - 3 1 -
SA01611110303Y- - 3 1 -
SA01611212099J- - 3 1 -
SA01611322592V- - 3 1 1
SA01611422489C- - 3 2 -
SA01611518352Z- - 3 2 -
SA01611623746B- - 3 2 -
SA01611720177Z- - 3 2 -
SA01611810458B- - 3 2 -
SA01611915665F- - 3 2 -
SA01612017794A- - 3 2 -
SA01612118605C- - 4 1 -
SA01612216738L- - 4 1 -
SA01612317573K- - 4 1 -
SA01612423966P- - 4 1 -
SA01612516463Y- - 4 2 -
SA01612622728U- - 4 2 -
SA01612719638W- - 4 2 -
SA01603420586Q- - - 1 -
SA01603525041Z- - - 1 -
SA01603620583K- - - 1 -
SA01603724304A- - - 1 -
SA01603824716X- - - 1 -
SA01603921654M- - - 1 -
Showing page 1 of 2     Results:    1  2  Next     Showing results 1 to 100 of 129

Collection:

Collection ID:CO000377
Collection Summary:Subjects had fresh frozen plasma collected using a p100 tube (BD) at two COPDGene sites (National Jewish Health and University of Iowa)
Sample Type:Blood

Treatment:

Treatment ID:TR000397
Treatment Summary:Association analysis was done between human subjects and statistical analysis performed using data collected from subjects using covariates and phenotypes as outcomes.

Sample Preparation:

Sampleprep ID:SP000390
Sampleprep Summary:Sphingomyelins, dihydrosphingomyelins, ceramides and dihydroceramides: A modified Bligh-Dyer extraction method was used in the presence of internal standards (IS). Sample analysis was performed in four batches using a Shimadzu 10A HPLC system coupled to a TSQ Quantum Ultra triple quadrupole mass spectrometer operated in SRM mode under ESI(+). A Thermo Betasil C18 column was employed to achieve the optimal sensitivity and separation. Data processing was conducted with Xcalibur software (Thermo) to obtain the peak area ratios of analytes to the corresponding internal standards (Supplemental Table 2). A pooled lipid extract from study samples was used as a quality control (QC) sample, and was injected between every 6 study samples to verify the instrument consistency. The peak area ratios were then normalized to the average of QC peak area ratios in the same batch, so that the results for different batches were brought to the same baseline. Sphingoid bases, ceramide-1-phosphate, monohexosylsphingosine, monohexosylceramides, dihexosylceramides, trihexosylceramides, monohydroxylated monohexosylceramides, monohydroxylated dihexosylceramides, sulfatides, and gangliosides: Plasma protein was precipitated with methanol, followed by supernatant collection, drying, and reconstituting with 1:1 methanol/water in the presence of internal standards. Duplicate sample analysis (1 st analysis and 2 nd analysis) was performed in four batches with an online trapping API-4000 system, (consists of a API-4000 mass spectrometer, a Leap PAL autosampler, an Agilent 1100 HPLC, and a Shimadzu HPLC) operated in multiple reaction monitoring (MRM) mode under ESI(+) for all species except sulfatides and E2gangliosides ESI(-). An Agilent Eclipse XRB-C18 column was used for sphingoid bases and ceramide-1- phosphate and a Varian Metasil C18 column was used for analysis of monohexosylsphingosine, mono-, di-, tri- hexosylceramides as well as their monohydroxylated ceramides. An Agilent Zobax Eclipse Plus C18 column was used for analysis of sulfatides and gangliosides. A Thermo Betasil C18 trapping column was also used for all analytes. Data processing was conducted with Analyst software (Applied Sciences) to obtain the peak area ratios of analytes to the corresponding internal standards. A pooled lipid extract from study samples was used as a quality control (QC) sample, and was injected between every 10 study samples to verify the instrumental consistency. All duplicated sample runs were averaged. The values for each sphingolipid were peak area ratios that were normalized to internal standard and then normalized to QC standards. Values were relative peak area ratios and unitless.

Combined analysis:

Analysis ID AN000594
Analysis type MS
Chromatography type Reversed phase
Chromatography system Shimadzu 10A
Column Thermo Betasil C18
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name Shimadzu 10A
Ion Mode POSITIVE
Units Peak Area Ratio

Chromatography:

Chromatography ID:CH000425
Chromatography Summary:A modified Bligh-Dyer extraction method was used in the presence of internal standards (IS). Sample analysis was performed in four batches with a Shimadzu 10A HPLC system coupled to a TSQ Quantum Ultra triple quadrupole mass spectrometer operated in SRM mode under ESI(+). A Thermo Betasil C18 column was employed to achieve the optimal sensitivity and separation.
Instrument Name:Shimadzu 10A
Column Name:Thermo Betasil C18
Chromatography Type:Reversed phase

MS:

MS ID:MS000530
Analysis ID:AN000594
Instrument Name:Shimadzu 10A
Instrument Type:Triple quadrupole
MS Type:ESI
Ion Mode:POSITIVE
  logo